What Does Wearable Technology Mean for Myeloproliferative Care?
https://vimeo.com/702236032 Myeloproliferative neoplasm (MPN) patients can add wearable technology as another part of their MPN care toolbox. Watch to learn about monitoring that wearable devices may provide, what it means…
Understanding What ECG Monitoring Tools Mean for MPN
https://vimeo.com/702235472 Myeloproliferative neoplasm (MPN) patients can add ECG monitoring tools as part of their care. Watch to learn about ECG monitoring tools, their value in MPN care, and future developments…
Health Educator Turned MPN Patient Speaks to Importance of Specialized Care
https://vimeo.com/619358448 Myeloproliferative neoplasm (MPN) patient and health educator Julia Olff helped others navigate the healthcare system before her diagnosis with myelofibrosis and later with ET. Watch as she shares her…
MPN Patient Shares Importance of Understanding Benefits of Professional Therapy
https://vimeo.com/619355903 Myelofibrosis patient Julia Olff shares her experience with seeing a professional therapist via telemedicine as part of her MPN care. See More From the MPN TelemEDucation Related Resources Understanding…
What MPN Side Effects Can Be Monitored With Telemedicine?
https://vimeo.com/581391804 For myeloproliferative neoplasm (MPN) patients, what are some side effects that can be monitored via telemedicine? Expert Dr. Jamile Shammo from Rush University Medical Center shares the types of symptom monitoring…
What Opportunities and Challenges Does Telemedicine Present for MPN Patients?
https://vimeo.com/581391819 For myeloproliferative neoplasm (MPN) patients, what does telemedicine offer in terms of opportunities and challenges? Expert Dr. Jamile Shammo from Rush University Medical Center shares situations when telemedicine versus in-person visits…
What Impact Does Telemedicine Have on Clinical Trials for MPN Patients?
https://vimeo.com/581391787 For myeloproliferative neoplasm (MPN) patients, what impact does telemedicine have on clinical trial access? Expert Dr. Jamile Shammo from Rush University Medical Center explains the current environment for clinical trial access…